Genentech Presents New Phase III Pivotal Data for Vamikibart in Uveitic Macular Edema , a Serious Cause of Vision Loss 8h
Genentech Expands Xofluza® Access and Affordability for Upcoming Flu Season With Direct-to-Patient Launch 16 October
Roche's Elecsys® pTau181 becomes the only FDA-cleared blood test for use in primary care to rule out Alzheimer's-related amyloid pathology 13 October
